Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Thoracic and Cardiovascular Surgery|May 6, 2025
The 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical Management of Esophageal and Gastroesophageal Junction CancerD Molena, M Sewell, S B Maron, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 8, 2010
Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary diseaseK H Chan, S C Yeung, T J Yao, et al.
The European Respiratory Journal|July 18, 2009
A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoeaJ C M Lam, B Lam, T J Yao, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Seminars in Oncology|August 1, 1993
Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancerA D Seidman, L Norton, B S Reichman, et al.
Cancer|April 15, 1993
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trialA Kritz, J P Crown, R J Motzer, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary reportA D Seidman, B S Reichman, J P Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline responseA D Seidman, B S Reichman, J P Crown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2011
The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoringK K L Chan, T J Yao, B Jones, et al.
Oncology|October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancerA D Seidman, L Norton, B S Reichman, et al.
Pageof 15